Skip to main content
Equibles

Frazier Life Sciences Management, L.P.

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 1892134 PALO ALTO, CA
Back to LXEO Full portfolio

Position in LXEO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$22,459,094
-$2,938,827 QoQ
Shares Held
4,824,725
+9.0% QoQ
Ownership
5.88%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#5
of 141 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LXEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Frazier Life Sciences Management, L.P. holds $4,497,017,185 across 37 Biotechnology names. LXEO ranks #31 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MIRM
Mirum Pharmaceuticals, Inc.
 7,679,684 $899,060,605
2 NAMS
NewAmsterdam Pharma Co N.V.
 18,589,235 $623,725,004
3 ERAS
Erasca, Inc.
 24,975,188 $457,545,444
4 MBX
MBX Biosciences, Inc.
 6,652,013 $367,191,117
5 ARQT
Arcutis Biotherapeutics, Inc.
 9,874,511 $258,909,678
6 TRVI
Trevi Therapeutics, Inc.
 9,939,447 $185,370,686
7 KRYS
Krystal Biotech, Inc.
 481,307 $178,887,372
8 MAZE
Maze Therapeutics, Inc.
 5,032,915 $150,182,183

All Filings in LXEO

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,459,094 4,824,725
2026-03-31 $25,397,921 4,424,725
2025-12-31 $43,937,519 4,424,725
2025-09-30 $29,380,174 4,424,725
2025-06-30 $17,787,394 4,424,725
2025-03-31 $3,315,637 955,515
2024-12-31 $6,287,288 955,515
2024-09-30 $11,307,105 1,250,786